Overview

Preventing Systemic Inflammation After Cardiac Surgery With Alkaline Phosphatase

Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
Study should demonstrate that alkaline phosphatase reduces the incidence and extent of acute kidney injury after cardiopulmonary bypass (CPB) as defined by the AKIN criteria.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Alloksys Life Sciences B.V.
Collaborator:
Aix Scientifics